IMWG Series

The International Myeloma Working Group (IMWG) Conference Series: Making Sense of Treatment is a medical education program created by the International Myeloma Foundation (IMF) to bring lively expert discussion of important myeloma treatment issues into the homes and offices of viewers around the world via live webcast.

Dec
03
IMWG Conference Series: 60th ASH Meeting
Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from the 2018 ASH Meeting at 8:00pm PT/10:00pm CT/11:00pm ET on Monday, December 3, 2018 . IMF Chairman Dr. Brian G.M. Durie, Dr. Maria Victoria Mateos from the University of Salamanca, Spain, and IMF Chief Medical Officer Dr. Joseph Mikhael will distill, debate, and discuss the latest news and trends in the treatment of multiple myeloma at the 60th Annual...
Dec
03
IMWG Conference Series: 60th ASH Meeting
Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from the 2018 ASH Meeting at 8:00pm PT/10:00pm CT/11:00pm(...)
Jun
14
Stockholm 2018: CAR T-cell Therapy
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about CAR T-cell therapy with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Sagar Lonial (Emory University, Atlanta(...)
Jun
14
Stockholm 2018: New Drugs in Multiple Myeloma
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about new drugs and drug combinations in the myeloma treatment landscape with Dr. Joseph Mikhael (IMF Chief Medical Officer(...)
Jun
14
Stockholm 2018: Cost of Care
Drs. Brian GM Durie, Joseph Mikhael, and Sagar Lonial discuss the cost of care for multiple myeloma.
Jun
14
Stockholm 2018: The Role of CRISPR Gene Editing
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about the role of CRISPR gene-editing in the landscape of multiple myeloma treatment with Dr. Joseph Mikhael (IMF Chief(...)
Jun
14
Stockholm 2018: The Role of Mass Spectrometry in Multiple Myeloma
In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about mass spectrometry with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Sagar Lonial (Emory University, Atlanta(...)

Give Where Needed Most

$500
$250
$100
$50
other

Learn More

 

We would like to thank:

Amgen, Astellas Pharma, Binding Site, Bristol-Myers Squibb, Celgene, Diplomat Pharmacy, Genentech, Hoffmann-La Roche, Janssen, Karyopharm Therapeutics, Merck, Novartis, Oncopeptides, Sanofi-Genzyme, Takeda Oncology